Advance Treatment for Colorectal Cancer
On behalf of the Journal of Colorectal Cancer: Open Access, as Editor-in-Chief, it is my distinct honour and privilege to inform you that, it’s been six long years we have started the Journal, now we are celebrating the 6th Anniversary and we are privileged to welcome Cancer Society to our journal. As Editor-In-Chief it is my great pleasure and honour to welcome you to the Journal of Colorectal Cancer: Open Access, Opening Issue of the Year.
Advanced bowel (colorectal) cancer is cancer of the colon or rectum that has spread to other parts of the body. In some people whose cancer has only spread to the liver or lungs, surgery and chemotherapy can keep the cancer under control for a long time and could possibly cure it.
In that year, the FDA approved the chemotherapy drug Camptosar for first-line use in people with metastatic colorectal cancer-cancer that has spread outside the colon and into other parts of the body. Studies show that people using a combination of Camptosar with other drugs lived longer than those using traditional chemotherapy. Submit Here
The conference is the effectively running independent life science events company with a predominantly academic client base. Our multiprofessional and multispeciality approach creates a unique experience that cannot be found with a specialist society or commercially.
Journal of Colorectal Cancer: Open Access
Email id firstname.lastname@example.org